A New Method to Cultivate Cord Blood Based High Proliferative Potential-Endothelial Progenitor Cells

SUN Xuan,MEI Hua,LU Guang-xiu,CHENG La-mei
DOI: https://doi.org/10.13207/j.cnki.jnwafu.2013.04.010
2013-01-01
Abstract:【Objective】 In this study,we aimed at establishing a stable and economic method to culture cord blood based high proliferative potential-endothelial progenitor cells(HPP-EPCs),and comparing HPP-EPCs derived EPCs with human umbilical vein endothelial cells(HUVECs) in vitro.【Method】 Mononuclear cells(MNCs) separated from human umbilical cord blood were suspended in MCDB131 containing VEGF and ECGS before being seeded onto cell culture plate pre-coated with fibronectin.Non-adherent cells were removed after 4 days of culture.10-21 days later,HPP-EPCs forming colonies appeared.HUVECs were separated from human umbilical cord vein,and expanded in MCDB131 containing EGF.We identified the endothelial cell population by immunophenotyping,UEA1 binding assay,Matrigel angiogenesis assay and DiI-acetylated-low density lipoprotein(DiI-Ac-LDL) uptaken assay.HUVECs were positive control,while hEFs were negative control.【Result】 A single HPP-EPC could generate as many as 108-1010 progenies in vitro within 2 months.They could remain normal karyotype after long-term culture.They expressed CD31,CD144,vWF,and binding UEA1,and could form capillary-like formation on Matrigel.They also had the ability to incorporate DiI-Ac-LDL.【Conclusion】 Our approach is more convenient and economic in culturing and expanding EPCs from umbilical cord blood,which makes EPCs an efficient seed cell type in treatment of ischemia diseases.
What problem does this paper attempt to address?